Tuesday, 18 Dec 2018

You are here

Daniel Lovell, MD: abatacept in JIA

Dr. Daniel Lovell, a pediatric rheumatologist from the University of Cincinnati/Cincinnati Children's Hospital Medical Center discusses a phase-4 study looking at the effectiveness and safety of abatacept in kids with JIA.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

RWCS 2017: Biosimilars

21 Feb 2017

Dr. Jack Cush: RheumNow at ACR 2018

21 Oct 2018

The Week in Review - 11 March 2016

11 Mar 2016

Dr. Allan Gibofsky: Cost of Care

07 Nov 2017

Dr. Patrick Wood: brain calcification...

02 Mar 2016

The RheumNow Week in Review – 11 August...

11 Aug 2017

Dr. Olga Petryna: Osteoporotic...

30 Oct 2018

Arthur F. Kavanaugh, MD: sessions on...

12 Nov 2015

Drs. Suleman Bhana, Paul Sufka and...

23 Oct 2018

Dr. Philip Mease: Risankizumab in...

18 Dec 2017

The RheumNow Week in Review –...

18 May 2018

Dr. Deodhar: tofacitinib, secukinumab...

11 Nov 2015